Advanced Proteome Therapeutics Corp (APC):企業の財務・戦略的SWOT分析

【英語タイトル】Advanced Proteome Therapeutics Corp (APC) - Financial and Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(DATA904C0591)・商品コード:DATA904C0591
・発行会社(調査会社):GlobalData
・発行日:2018年7月
・ページ数:42
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Advanced Proteome Therapeutics Corp (APC) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Advanced Proteome Therapeutics Corporation (APC) is a biopharmaceutical company that focuses on the development of anticancer therapeutics that capitalizes on the properties of a natural human protein. It creates, develops and commercializes novel therapies. The company is advancing a site-specific protein modification technology platform for the development of proprietary human protein pharmaceuticals with enhanced therapeutic properties and greater affinity for the target cancer cells and tumors. The patent pending technology combines anti-cancer therapies in a single agent to directly target cancerous tumors and avoid destroying normal cells. The company carries out its operations through its subsidiary; Advanced Proteome Therapeutics Inc. APC is headquartered in Boston, Massachusetts, the US.

Advanced Proteome Therapeutics Corp Key Recent Developments

Jun 18,2018: Advanced Proteome Therapeutics Advances its Technological Capability
Jun 06,2018: Advanced Proteome Therapeutics Names Bill Dickie As Chief Executive Officer, President And Director
May 01,2018: Advanced Proteome Therapeutics Updates its Activities During the 3rd Quarter, FY 2018
Apr 24,2018: Advanced Proteome Therapeutics Announces Appointment of Scientific Advisory Board Members
Apr 16,2018: Advanced Proteome Therapeutics Announces Resignation Of Randal Chase As CEO And Director

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Advanced Proteome Therapeutics Corp – Key Facts 5
Advanced Proteome Therapeutics Corp – Key Employees 6
Advanced Proteome Therapeutics Corp – Key Employee Biographies 7
Advanced Proteome Therapeutics Corp – Major Products and Services 8
Advanced Proteome Therapeutics Corp – History 9
Advanced Proteome Therapeutics Corp – Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2 – Company Analysis 12
Company Overview 12
Advanced Proteome Therapeutics Corp – Business Description 13
Advanced Proteome Therapeutics Corp – SWOT Analysis 14
SWOT Analysis – Overview 14
Advanced Proteome Therapeutics Corp – Strengths 14
Advanced Proteome Therapeutics Corp – Weaknesses 15
Advanced Proteome Therapeutics Corp – Opportunities 16
Advanced Proteome Therapeutics Corp – Threats 17
Advanced Proteome Therapeutics Corp – Key Competitors 18
Section 3 – Company Financial Ratios 19
Financial Ratios – Capital Market Ratios 19
Financial Ratios – Annual Ratios 20
Performance Chart 22
Financial Performance 22
Financial Ratios – Interim Ratios 23
Financial Ratios – Ratio Charts 24
Section 4 – Company’s Lifesciences Financial Deals and Alliances 25
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 26
Advanced Proteome Therapeutics Corp, Recent Deals Summary 27
Section 5 – Company’s Recent Developments 28
Jun 18, 2018: Advanced Proteome Therapeutics Advances its Technological Capability 28
May 01, 2018: Advanced Proteome Therapeutics Updates its Activities During the 3rd Quarter, FY 2018 29
Apr 24, 2018: Advanced Proteome Therapeutics Announces Appointment of Scientific Advisory Board Members 30
Feb 05, 2018: Advanced Proteome Therapeutics Announces New Patent Grant 31
Jan 31, 2018: Advanced Proteome Therapeutics Announces Anti-Cancer R&D Gathers Momentum 32
Jan 08, 2018: Heidelberg Pharma and Advanced Proteome Therapeutics Progress Collaborative Program 33
Jul 31, 2017: Advanced Proteome Therapeutics Announces 2017 AGM Results and Corporate Update 34
Jul 18, 2017: Advanced Proteome Therapeutics Announces Collaboration to Develop Cancer Therapeutic 35
May 18, 2017: Advanced Proteome Therapeutics Advances Collaborations 36
Feb 06, 2017: Advanced Proteome Therapeutics Announces the Appointment of Dr. Randal Chase to Its Executive Leadership Team 37
Section 6 – Appendix 38
Methodology 38
Ratio Definitions 38
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
Advanced Proteome Therapeutics Corp, Key Facts 5
Advanced Proteome Therapeutics Corp, Key Employees 6
Advanced Proteome Therapeutics Corp, Key Employee Biographies 7
Advanced Proteome Therapeutics Corp, Major Products and Services 8
Advanced Proteome Therapeutics Corp, History 9
Advanced Proteome Therapeutics Corp, Other Locations 11
Advanced Proteome Therapeutics Corp, Subsidiaries 11
Advanced Proteome Therapeutics Corp, Key Competitors 18
Advanced Proteome Therapeutics Corp, Ratios based on current share price 19
Advanced Proteome Therapeutics Corp, Annual Ratios 20
Advanced Proteome Therapeutics Corp, Annual Ratios (Cont...1) 21
Advanced Proteome Therapeutics Corp, Interim Ratios 23
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 26
Advanced Proteome Therapeutics Corp, Recent Deals Summary 27
Currency Codes 38
Capital Market Ratios 38
Equity Ratios 39
Profitability Ratios 39
Cost Ratios 40
Liquidity Ratios 40
Leverage Ratios 41
Efficiency Ratios 41

List of Figures
Advanced Proteome Therapeutics Corp, Performance Chart (2013 - 2017) 22
Advanced Proteome Therapeutics Corp, Ratio Charts 24
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 26

★調査レポート[Advanced Proteome Therapeutics Corp (APC):企業の財務・戦略的SWOT分析] (コード:DATA904C0591)販売に関する免責事項を必ずご確認ください。
★調査レポート[Advanced Proteome Therapeutics Corp (APC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆